D-0709-2026 Class II Ongoing

Recalled by Major Pharmaceuticals — Dublin, OH

FDA drug recall D-0709-2026 was initiated by Major Pharmaceuticals on Jul 13, 2026 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Jul 29, 2026
Initiation Date
Jul 13, 2026
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3560-0; NDC Blister: 0904-6951-61

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide in the USA.

Code information

Bag lot #: N02172A, N02172B, Exp. Date 07/2026; N02288A, N02288B, Exp. Date 12/2026; Blister lot #: N02172, Exp. Date 07/2026; N02288, Exp. Date 12/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0709-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0709-2026. Report a data issue: hello@regdatalab.com.